{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:02:16Z","timestamp":1773864136544,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Oncology"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/s1470-2045(09)70154-8","type":"journal-article","created":{"date-parts":[[2009,6,9]],"date-time":"2009-06-09T05:05:15Z","timestamp":1244523915000},"page":"663-671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":162,"title":["Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN\/COG\/GPOH study"],"prefix":"10.1016","volume":"10","author":[{"given":"Jo\u00eblle","family":"Vermeulen","sequence":"first","affiliation":[]},{"given":"Katleen","family":"De Preter","sequence":"additional","affiliation":[]},{"given":"Arlene","family":"Naranjo","sequence":"additional","affiliation":[]},{"given":"Liesbeth","family":"Vercruysse","sequence":"additional","affiliation":[]},{"given":"Nadine","family":"Van Roy","sequence":"additional","affiliation":[]},{"given":"Jan","family":"Hellemans","sequence":"additional","affiliation":[]},{"given":"Katrien","family":"Swerts","sequence":"additional","affiliation":[]},{"given":"Sophie","family":"Bravo","sequence":"additional","affiliation":[]},{"given":"Paola","family":"Scaruffi","sequence":"additional","affiliation":[]},{"given":"Gian Paolo","family":"Tonini","sequence":"additional","affiliation":[]},{"given":"Bruno","family":"De Bernardi","sequence":"additional","affiliation":[]},{"given":"Rosa","family":"Noguera","sequence":"additional","affiliation":[]},{"given":"Marta","family":"Piqueras","sequence":"additional","affiliation":[]},{"given":"Adela","family":"Ca\u00f1ete","sequence":"additional","affiliation":[]},{"given":"Victoria","family":"Castel","sequence":"additional","affiliation":[]},{"given":"Isabelle","family":"Janoueix-Lerosey","sequence":"additional","affiliation":[]},{"given":"Olivier","family":"Delattre","sequence":"additional","affiliation":[]},{"given":"Gudrun","family":"Schleiermacher","sequence":"additional","affiliation":[]},{"given":"Jean","family":"Michon","sequence":"additional","affiliation":[]},{"given":"Val\u00e9rie","family":"Combaret","sequence":"additional","affiliation":[]},{"given":"Matthias","family":"Fischer","sequence":"additional","affiliation":[]},{"given":"Andr\u00e9","family":"Oberthuer","sequence":"additional","affiliation":[]},{"given":"Peter F","family":"Ambros","sequence":"additional","affiliation":[]},{"given":"Klaus","family":"Beiske","sequence":"additional","affiliation":[]},{"given":"Jean","family":"B\u00e9nard","sequence":"additional","affiliation":[]},{"given":"B\u00e1rbara","family":"Marques","sequence":"additional","affiliation":[]},{"given":"Herv\u00e9","family":"Rubie","sequence":"additional","affiliation":[]},{"given":"Janice","family":"Kohler","sequence":"additional","affiliation":[]},{"given":"Ulrike","family":"P\u00f6tschger","sequence":"additional","affiliation":[]},{"given":"Ruth","family":"Ladenstein","sequence":"additional","affiliation":[]},{"given":"Michael D","family":"Hogarty","sequence":"additional","affiliation":[]},{"given":"Patrick","family":"McGrady","sequence":"additional","affiliation":[]},{"given":"Wendy B","family":"London","sequence":"additional","affiliation":[]},{"given":"Genevi\u00e8ve","family":"Laureys","sequence":"additional","affiliation":[]},{"given":"Frank","family":"Speleman","sequence":"additional","affiliation":[]},{"given":"Jo","family":"Vandesompele","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S1470-2045(09)70154-8_bib1","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(07)60983-0","article-title":"Neuroblastoma","volume":"369","author":"Maris","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/S1470-2045(09)70154-8_bib2","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/415530a","article-title":"Gene expression profiling predicts clinical outcome of breast cancer","volume":"415","author":"van 't Veer","year":"2002","journal-title":"Nature"},{"key":"10.1016\/S1470-2045(09)70154-8_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa063994","article-title":"The prognostic role of a gene signature from tumorigenic breast-cancer cells","volume":"356","author":"Liu","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S1470-2045(09)70154-8_bib4","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(05)17947-1","article-title":"Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer","volume":"365","author":"Wang","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/S1470-2045(09)70154-8_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa060096","article-title":"A five-gene signature and clinical outcome in non-small-cell lung cancer","volume":"356","author":"Chen","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S1470-2045(09)70154-8_bib6","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1200\/JCO.2006.06.1879","article-title":"Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification","volume":"24","author":"Oberthuer","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/S1470-2045(09)70154-8_bib7","doi-asserted-by":"crossref","first-page":"6050","DOI":"10.1158\/0008-5472.CAN-05-4618","article-title":"Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number","volume":"66","author":"Wang","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/S1470-2045(09)70154-8_bib8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1535-6108(02)00179-4","article-title":"Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma","volume":"2","author":"Berwanger","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/S1470-2045(09)70154-8_bib9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ccr.2005.03.019","article-title":"Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate risk neuroblastomas","volume":"7","author":"Ohira","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/S1470-2045(09)70154-8_bib10","doi-asserted-by":"crossref","first-page":"7902","DOI":"10.1038\/sj.onc.1208936","article-title":"Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling","volume":"24","author":"Schramm","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/S1470-2045(09)70154-8_bib11","doi-asserted-by":"crossref","first-page":"R84","DOI":"10.1186\/gb-2006-7-9-r84","article-title":"Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes","volume":"7","author":"De Preter","year":"2006","journal-title":"Genome Biol"},{"key":"10.1016\/S1470-2045(09)70154-8_bib12","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/carcin\/bgh173","article-title":"Oligonucleotide microarray analysis of gene expression in neuroblastoma displaying loss of chromosome 11q","volume":"25","author":"McArdle","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1016\/S1470-2045(09)70154-8_bib13","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1073\/pnas.082099299","article-title":"Diagnosis of multiple cancer types by shrunken centroids of gene expression","volume":"99","author":"Tibshirani","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1470-2045(09)70154-8_bib14","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1200\/JCO.2008.17.5877","article-title":"Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification","volume":"27","author":"De Bernardi","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/S1470-2045(09)70154-8_bib15","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1200\/JCO.2007.14.5839","article-title":"Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: the International Society of Paediatric Oncology European Neuroblastoma Experience","volume":"27","author":"Canete","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/S1470-2045(09)70154-8_bib16","unstructured":"Kohler J, Rubie H, Castel V, Garaventa A, Haupt R. The treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: a SIOPEN study. Advances in Neuroblastoma Research; Chiba, Japan; May 21\u201324, 2008; Abstr C19."},{"key":"10.1016\/S1470-2045(09)70154-8_bib17","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/sj.bjc.6604640","article-title":"Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group","volume":"99","author":"De Bernardi","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/S1470-2045(09)70154-8_bib18","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.mam.2005.12.003","article-title":"RNA integrity and the effect on the real-time qRT-PCR performance","volume":"27","author":"Fleige","year":"2006","journal-title":"Mol Aspects Med"},{"key":"10.1016\/S1470-2045(09)70154-8_bib19","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ab.2006.01.051","article-title":"SPUD: a quantitative PCR assay for the detection of inhibitors in nucleic acid preparations","volume":"351","author":"Nolan","year":"2006","journal-title":"Anal Biochem"},{"key":"10.1016\/S1470-2045(09)70154-8_bib20","doi-asserted-by":"crossref","first-page":"D942","DOI":"10.1093\/nar\/gkn777","article-title":"RTPrimerDB: the portal for real-time PCR primers and probes","volume":"37","author":"Lefever","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/S1470-2045(09)70154-8_bib21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ccr.2006.05.001","article-title":"The challenges of gene expression microarrays for the study of human cancer","volume":"9","author":"Tinker","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/S1470-2045(09)70154-8_bib22","doi-asserted-by":"crossref","first-page":"9735","DOI":"10.1158\/0008-5472.CAN-07-6866","article-title":"ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma","volume":"68","author":"Hogarty","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/S1470-2045(09)70154-8_bib23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1158\/1078-0432.CCR-05-1431","article-title":"Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients","volume":"12","author":"Henrich","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S1470-2045(09)70154-8_bib24","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/jnci\/djn176","article-title":"CHD5, a tumor-suppressor gene deleted from 1p36.31 in neuroblastomas","volume":"100","author":"Fujita","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S1470-2045(09)70154-8_bib25","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/01.mph.0000212937.00287.e5","article-title":"Survivin mRNA levels are associated with biology of disease and patient survival in neuroblastoma: a report from the children's oncology group","volume":"28","author":"Miller","year":"2006","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/S1470-2045(09)70154-8_bib26","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/cncr.23720","article-title":"Identification of low intratumoral gene expression heterogeneity in neuroblastic tumors by genome-wide expression analysis and game theory","volume":"113","author":"Albino","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/S1470-2045(09)70154-8_bib27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1471-2407-8-173","article-title":"CADM1 is a strong neuroblastoma candidate gene that maps within a 3.72 Mb critical region of loss on 11q23","volume":"8","author":"Michels","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/S1470-2045(09)70154-8_bib28","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1038\/sj.onc.1210996","article-title":"Expression of the tumour suppressor gene CADM1 is associated with favourable outcome and inhibits cell survival in neuroblastoma","volume":"27","author":"Nowacki","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/S1470-2045(09)70154-8_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1471-2164-9-177","article-title":"A gene sets approach for identifying prognostic gene signatures for outcome prediction","volume":"9","author":"Kim","year":"2008","journal-title":"BMC Genomics"},{"key":"10.1016\/S1470-2045(09)70154-8_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.gde.2008.01.003","article-title":"Pathways connecting inflammation and cancer","volume":"18","author":"Allavena","year":"2008","journal-title":"Curr Opin Genet Dev"}],"container-title":["The Lancet Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470204509701548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470204509701548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:00:33Z","timestamp":1761458433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470204509701548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S1470204509701548"],"URL":"https:\/\/doi.org\/10.1016\/s1470-2045(09)70154-8","relation":{},"ISSN":["1470-2045"],"issn-type":[{"value":"1470-2045","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN\/COG\/GPOH study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S1470-2045(09)70154-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S1470-2045(09)70176-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}